Alembic Pharmaceuticals Limited (BOM:533573)
India · Delayed Price · Currency is INR 783.25
+12.30 (1.60%)
At close: Oct 28, 2026
Alembic Pharmaceuticals Market Cap
Alembic Pharmaceuticals has a market cap or net worth of 153.87 billion as of October 28, 2026. Its market cap has decreased by 14.44% in one year.
Market Cap
153.87B
Enterprise Value
166.15B
Revenue
77.84B
Global Rank
n/a
Country Rank
n/a
PE Ratio
22.20
ChartMarket Cap Chart
Since September 21, 2011, Alembic Pharmaceuticals's market cap has increased from 9.00B to 153.87B, an increase of 1,609.35%. That is a compound annual growth rate of 20.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 153.87B | -7.49% |
| Dec 31, 2025 | 166.32B | -20.64% |
| Dec 31, 2024 | 209.59B | 40.41% |
| Dec 29, 2023 | 149.27B | 32.55% |
| Dec 30, 2022 | 112.61B | -28.56% |
| Dec 31, 2021 | 157.62B | -22.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wockhardt | 306.14B |
| Piramal Pharma | 263.55B |
| Cohance Lifesciences | 181.98B |
| Eris Lifesciences | 165.79B |
| Alivus Life Sciences | 164.83B |
| Alembic Pharmaceuticals | 150.90B |
| NATCO Pharma | 142.28B |
| Sudeep Pharma | 115.66B |